Literature DB >> 22665943

Electronically Rich N-Substituted Tetrahydroisoquinoline 3-Carboxylic Acid Esters: Concise Synthesis and Conformational Studies.

Rami A Al-Horani1, Umesh R Desai.   

Abstract

Recent work in our laboratory has shown that the highly substituted, electronically rich 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (THIQ3CA) scaffold is a key building block for a novel class of promising anticoagulants (Al-Horani et al. J. Med. Chem.2011, 54, 6125-6138). The synthesis of THIQ3CA analogs, especially containing specific, electronically rich substituents, has been a challenge and essentially no efficient methods have been reported in the literature. We describe three complementary, glycine donor-based strategies for high yielding synthesis of highly substituted, electronically rich THIQ3CA esters. Three glycine donors studied herein include hydantoin 1, (±)-Boc-α-phosphonoglycine trimethyl ester 2 and (±)-Z-α-phosphonoglycine trimethyl ester 3. Although the synthesis of THIQ3CA analogs could be achieved using either of the three, an optimal, high yielding approach for the desired THIQ3CA esters was best achieved using 3 in three mild, efficient steps. Using this approach, a focused library of advanced N-arylacyl, N-arylalkyl, and bis-THIQ3CA analogs was synthesized. Variable temperature and solvent-dependent NMR chemical shift studies indicated the presence of two major conformational rotamers in 3:1 proportion for N-arylacyl-THIQ3CA analogs, which were separated by a high kinetic barrier of ~17 kcal/mol. In contrast, N-arylalkyl and bis-THIQ3CA variants displayed no rotamerism, which implicates restricted rotation around the amide bond as the origin for high-barrier conformational interconversion. This phenomenon is of major significance because structure-based drug design typically utilizes only one conformation. Overall, the work presents fundamental studies on the synthesis and conformational properties of highly substituted, electronically rich THIQ3CA analogs.

Entities:  

Year:  2012        PMID: 22665943      PMCID: PMC3365611          DOI: 10.1016/j.tet.2012.01.005

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  22 in total

1.  Highly enantioselective catalytic acyl-pictet-spengler reactions.

Authors:  Mark S Taylor; Eric N Jacobsen
Journal:  J Am Chem Soc       Date:  2004-09-01       Impact factor: 15.419

2.  Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.

Authors:  Hiroshi Ueno; Katsuyuki Yokota; Jun-Ichi Hoshi; Katsutaka Yasue; Mikio Hayashi; Yasunori Hase; Itsuo Uchida; Kazuo Aisaka; Susumu Katoh; Hidetsura Cho
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

Review 3.  The challenge of atropisomerism in drug discovery.

Authors:  Jonathan Clayden; Wesley J Moran; Paul J Edwards; Steven R LaPlante
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

4.  The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.

Authors:  Nigel S Watson; Carl Adams; David Belton; David Brown; Cynthia L Burns-Kurtis; Laiq Chaudry; Chuen Chan; Máire A Convery; David E Davies; Anne M Exall; John D Harling; Stephanie Irvine; Wendy R Irving; Savvas Kleanthous; Iain M McLay; Anthony J Pateman; Angela N Patikis; Theresa J Roethke; Stefan Senger; Gary J Stelman; John R Toomey; Robert I West; Caroline Whittaker; Ping Zhou; Robert J Young
Journal:  Bioorg Med Chem Lett       Date:  2011-02-02       Impact factor: 2.823

5.  Bis-tetrahydroisoquinoline derivatives: structure analysis of the three stereoisomers of 1,1'-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline).

Authors:  Johan Wouters; Kossay Elasaad; Bernadette Norberg; Amaury Graulich; Jean-François Liégeois
Journal:  Eur J Med Chem       Date:  2010-03-25       Impact factor: 6.514

6.  Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.

Authors:  Rami A Al-Horani; Aiye Liang; Umesh R Desai
Journal:  J Med Chem       Date:  2011-08-12       Impact factor: 7.446

7.  A new synthetic approach to 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) derivatives via a [2 + 2 + 2] cycloaddition reaction.

Authors:  S Kotha; N Sreenivasachary
Journal:  Bioorg Med Chem Lett       Date:  2000-07-03       Impact factor: 2.823

8.  Synthetic study toward ecteinascidin 743: concise construction of the diazabicyclo[3.3.1]nonane skeleton and assembly of the pentacyclic core.

Authors:  Taro Enomoto; Yoshizumi Yasui; Yoshiji Takemoto
Journal:  J Org Chem       Date:  2010-07-16       Impact factor: 4.354

9.  Solid-phase intramolecular N-acyliminium Pictet-Spengler reactions as crossroads to scaffold diversity.

Authors:  Thomas E Nielsen; Morten Meldal
Journal:  J Org Chem       Date:  2004-05-28       Impact factor: 4.354

10.  Synthesis and biological evaluation of (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: a novel series of PPAR gamma agonists.

Authors:  Satoru Azukizawa; Masayasu Kasai; Kenji Takahashi; Tomohiro Miike; Kazuyoshi Kunishiro; Mamoru Kanda; Chisato Mukai; Hiroaki Shirahase
Journal:  Chem Pharm Bull (Tokyo)       Date:  2008-03       Impact factor: 1.645

View more
  2 in total

1.  Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.

Authors:  Rami A Al-Horani; Pooja Ponnusamy; Akul Y Mehta; David Gailani; Umesh R Desai
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

Review 2.  The Pictet-Spengler Reaction Updates Its Habits.

Authors:  Andrea Calcaterra; Laura Mangiardi; Giuliano Delle Monache; Deborah Quaglio; Silvia Balducci; Simone Berardozzi; Antonia Iazzetti; Roberta Franzini; Bruno Botta; Francesca Ghirga
Journal:  Molecules       Date:  2020-01-19       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.